Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Future NDAC meetings

This article was originally published in The Tan Sheet

Executive Summary

Future NDAC meetings: On Jan. 22, the Nonprescription and Anti-infective Drugs Advisory Committees will jointly meet to discuss an antimicrobial health care continuum model, FDA said. The Cosmetic, Toiletry & Fragrance Association and the Soap & Detergent Association will make a joint presentation on the model at the meeting. CTFA and SDA proposed the HCCM to expand FDA's health care antiseptic categories, outlined in the June 1994 tentative final monograph on topical antiseptic drug products, to include general-use handwash, general-use bodywash and food handlers' handwash categories. Also, NDAC will meet jointly with the Cardio-Renal Drugs Advisory Committee on Jan. 23 to discuss professional labeling for indications for aspirin. The meetings will be held at the Gaithersburg Holiday Inn, beginning at 8:30 a.m. both days...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel